About Bellbrook labs
BellBrook Labs: Accelerating Drug Discovery with Innovative Solutions
BellBrook Labs is a leading provider of innovative lead discovery and optimization solutions for enzyme drug targets. The company has been at the forefront of drug discovery research for over two decades, helping pharmaceutical and biotech companies accelerate their drug development programs.
With a team of experienced scientists and cutting-edge technology, BellBrook Labs offers a range of products and services that enable researchers to identify, validate, and optimize potential drug candidates quickly and efficiently. The company's focus on enzyme targets has made it a go-to partner for many in the industry.
In this article, we will take an in-depth look at BellBrook Labs' history, products, services, partnerships, and future plans. We will also explore how the company's solutions are helping to revolutionize the field of drug discovery.
History
BellBrook Labs was founded in 1999 by Dr. Robert Lowery as a spin-off from the University of Wisconsin-Madison. Dr. Lowery had previously worked as a professor at UW-Madison's Department of Biochemistry before starting his own venture.
The company initially focused on developing high-throughput screening assays for G protein-coupled receptors (GPCRs), which are important targets for many drugs. Over time, BellBrook expanded its offerings to include assays for other types of enzymes such as kinases and phosphatases.
Today, BellBrook is recognized as one of the leading providers of assay technologies for enzyme targets in drug discovery research.
Products
BellBrook offers several products that help researchers identify potential drug candidates quickly and efficiently:
Transcreener Assays: These assays use fluorescence polarization or TR-FRET detection to measure enzymatic activity directly without requiring labeled substrates or antibodies.
AptaFluor SAH Methyltransferase Assay: This assay measures methyltransferase activity using an aptamer-based detection system.
iuvo Microconduit Array Technology: This platform enables high-throughput cell-based assays by creating microfluidic channels that allow cells to be cultured under controlled conditions.
Custom Assay Development Services: Bellbrook can develop custom assays tailored to specific needs using its expertise in assay design and optimization.
Services
In addition to its product offerings, Bellbrook provides several services that help researchers optimize their lead compounds:
Lead Discovery Services: These services use Transcreener HTS assays combined with medicinal chemistry expertise to identify novel leads against challenging enzyme targets.
Lead Optimization Services: These services use Transcreener biochemical kinase or methyltransferase assays combined with medicinal chemistry expertise to optimize leads into potent inhibitors suitable for preclinical development.
Assay Development Services: These services provide customized assay development support tailored specifically towards your target class or project needs
Consulting Services - Our team can provide expert guidance on all aspects related to your project including target selection & validation; hit identification & confirmation; lead optimization & profiling; ADME-Tox studies; patent strategy & IP protection etc..
Partnerships
Over the years,Bellbrook has established partnerships with several pharmaceutical companies,bio-tech firms,and academic institutions.Their collaborations have resulted in numerous publications,presentations,and patents.Bellbrook’s partners include Pfizer,AstraZeneca,Sanofi-Aventis,GSK,Bristol-Myers Squibb,Celgene Corporation,National Institutes Of Health(NIH),and many more.Bellbrook’s partnership network helps them stay up-to-date on emerging trends within their industry while also providing valuable resources such as funding,support staff,and access scientific equipment not available elsewhere.This allows them continue innovating new technologies which ultimately benefits everyone involved including patients who benefit from new treatments developed through these collaborations.
Future Plans
As part of its ongoing commitment towards innovation,Bellbrooks labs continues investing heavily into R&D efforts aimed at developing new technologies designed specifically around improving efficiency during early stage research phases.They plan on expanding their product line further by introducing additional tools designed around optimizing workflows within laboratories while also continuing work towards identifying novel therapeutic agents against challenging disease states.In addition they plan on expanding their global reach through strategic partnerships across different regions worldwide.
Conclusion
In conclusion,Bellbrooks labs is an innovative leader within the fieldofdrugdiscoveryresearch.Their focusonenzyme-targetedassaysandmedicinalchemistryexpertisehasenabledthemtohelpnumerouspharmaceuticalcompaniesandbiotechfirmsacceleratetheirdrugdevelopmentprograms.Thecompanycontinuesinnovatingnewtechnologiesaimedatsolvingchallengingproblemswithintheindustrywhilealsopartneringwithotherorganizationsinordertobringnewtreatmentsintothemarketplacefasterthaneverbefore.If you're lookingforapartnerthatcanhelpyouaccelerateyourdrugdiscoveryprogram,you should definitely consider working with Bellbrooks labs.Contact them today!